Who is sponsoring NCT03261804?

NCT03261804 is sponsored by Assiut University.

What drugs are being tested in NCT03261804?

Interventions in NCT03261804: relation between vaginal douching and vaginal infection.

What condition does NCT03261804 study?

NCT03261804 studies Vaginal Infection.

Is NCT03261804 still recruiting?

NCT03261804 is currently completed. Last updated 25 May 2022.

Last reviewed 2022-05-25 · How we verify

NCT03261804

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Relation Between Internal Vaginal Douching and Vaginal Infections in Intrauterine Contraceptive Device Users

Completed Last updated 25 May 2022

What this trial tests

trial testing relation between vaginal douching and vaginal infection in Vaginal Infection in 604 participants. Completed in 1 August 2021.

Timeline

1 June 2018

Primary endpoint
1 August 2021

1 August 2021

Quick facts

Lead sponsor	Assiut University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	604
Start date	1 June 2018
Primary completion	1 August 2021
Estimated completion	1 August 2021
Sites	1 location across Egypt

Drugs / interventions tested

relation between vaginal douching and vaginal infection

Conditions studied

Vaginal Infection — all drugs for Vaginal Infection →

Sponsor

Assiut University

Who can join

Adults 18 to 48, female only, with Vaginal Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To determine the effect of performing internal vaginal douching on the frequency and severity and type of vaginal infections in IUD users

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03261804 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 25 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03261804.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing